Showing 1,161 - 1,180 results of 8,597 for search 'effective dysfunction', query time: 0.12s Refine Results
  1. 1161
  2. 1162

    Efficacy of tadalafil on improvement of men with erectile dysfunction caused by COVID-19: A randomized placebo-controlled trial by Iman Shamohammadi, Seyedmohammad Kazemeyni, Mohammadali Sadighi, Tara Hasanzadeh, Alireza Dizavi

    Published 2024-01-01
    “…Conclusion: Daily administration of tadalafil 5 mg seems to be effective and safe for improvement of erectile dysfunction caused by COVID-19.…”
    Get full text
    Article
  3. 1163

    Point of care creatinine testing for early detection of renal dysfunction in Tanzanian HIV patients: a study protocol by Daniel Msilanga, Anthony Muiru, Emmanuel Balandya, Kathleen Liu

    Published 2024-11-01
    “…The diagnostic performance and agreement to diagnose renal dysfunction will be assessed using a standardized statistical approach: Bland-Altman analysis and linear mixed-effects models to test agreement between creatinine dipstick tests with serum creatinine. …”
    Get full text
    Article
  4. 1164

    Low-Intensity Extracorporeal Shockwave Therapy – A New Approach in the Treatment of Erectile Dysfunction after Radical Prostatectomy by Boyan Stoykov, Nikolay Kolev, Rumen P.Kotsev, Fahd Al-Shargabi, Pencho Genov, Aleksandar Vanov

    Published 2018-03-01
    “…The experience accumulated with low-intensity extracorporeal shock wave therapy (LI-ESWT) from international clinical trials has demonstrated its safety, efficacy and good tolerance in treatment of erectile dysfunction (ED). The aim of this retrospective study was to investigate the effect of LI-ESWT in patients with ED after bilateral nerve sparing radical surgery for prostate cancer. …”
    Get full text
    Article
  5. 1165

    A comparative study of the anti-ischemic activity of trimetazidine and the compound ALM-802 under conditions of endothelial dysfunction by V. V. Barchukov, I. B. Tsorin, A. M. Likhosherstov, M. B. Vititnova, G. V. Mokrov, S. A. Kryzhanovskii

    Published 2019-02-01
    “…Conclusion. Endothelial dysfunction prevents the implementation of the trimetazidine anti-ischemic action, but does not affect on the compound ALM-802 effect. …”
    Get full text
    Article
  6. 1166

    Non-coding RNA-mediated granulosa cell dysfunction during ovarian aging: From mechanisms to potential interventions by Li Dong, Haicui Wu, Fanghua Qi, Yuan Xu, Wen Chen, Yuqi Wang, Pingping Cai

    Published 2025-06-01
    “…The exact pathogenesis of ovarian aging (OA) remains incompletely understood, with granulosa cells (GCs) dysfunction playing a significant role in this process. …”
    Get full text
    Article
  7. 1167
  8. 1168

    Unveiling Therapeutic Potential of Yoga Mitigating Oxidative Stress and Mitochondrial Dysfunction in PCOS: A Randomized Controlled Trial by Deepika Kumari, Manoj Kumar, Ashish Datt Upadhyay, Neena Malhotra, Reeta Mahey, Vatsala Dadhwal, Tushar Sehgal, Richa Mishra, Rima Dada

    Published 2025-01-01
    “…Background: Hormonal imbalance, mitochondrial dysfunctions, and oxidative stress (OS) have been implicated in the pathogenesis of polycystic ovarian syndrome (PCOS) and its associated clinical features. …”
    Get full text
    Article
  9. 1169

    A Mitochondria‐Targeted Biomimetic Nanomedicine Capable of Reversing Drug Resistance in Colorectal Cancer Through Mitochondrial Dysfunction by Xiaohui Wang, Zhiyuan Xu, Jian Wang, Chunrong Wu, Lin Zhang, Chengyuan Qian, Yang Luo, Yanjuan Gu, Wing‐Tak Wong, Debing Xiang

    Published 2025-04-01
    “…Abstract Chemoresistance and metastasis are the main obstacles to the clinical success of anticancer treatment and are responsible for most cancer deaths. Developing effective approaches to reverse chemoresistance and inhibit metastasis is essential for efficient chemotherapy. …”
    Get full text
    Article
  10. 1170

    Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Evolving Insights into Pathogenesis, Progression, and Personalized Treatment Approaches by Paweł Kukiełka, Katarzyna Moliszewska, Joanna Kośka, Kacper Dywan, Michał Błaszkiewicz, Julia Mazurek, Julia Załęcka, Alicja Nowik, Martyna Musiorska, Gabriela Łocik

    Published 2025-07-01
    “…   Background: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), previously classified under non-alcoholic fatty liver disease (NAFLD), is an increasingly prevalent chronic liver disorder tightly linked to obesity, insulin resistance, and systemic metabolic dysfunction. …”
    Get full text
    Article
  11. 1171

    Integrated bioinformatics and experiment validation reveal cuproptosis-related biomarkers and therapeutic targets in sepsis-induced myocardial dysfunction by Xuemei Shi, Zhonghan Yan, Ruilin Ding, Fenfen Xia, Yan Du, Xiaojie Wang, Qing Peng

    Published 2025-03-01
    “…The lack of early, specific biomarkers and effective treatments necessitates exploration of novel mechanisms. …”
    Get full text
    Article
  12. 1172

    Angiotensin II Induces Vascular Endothelial Dysfunction by Promoting Lipid Peroxidation-Mediated Ferroptosis via CD36 by Qian Zhou, Ying Zhang, Wei Shi, Lu Lu, Jianglan Wei, Jinhan Wang, Hu Zhang, Yuepu Pu, Lihong Yin

    Published 2024-11-01
    “…Angiotensin II (Ang II) is an effective vasoconstriction peptide, a major effector molecule of the renin–angiotensin–aldosterone system (RAAS) and one of the important causes of endothelial dysfunction. …”
    Get full text
    Article
  13. 1173
  14. 1174

    Spleen tyrosine kinase: a novel pharmacological target for sepsis-induced cardiac dysfunction and multi-organ failure by Chiara Verra, Maria Kerstin Paulmann, Maria Kerstin Paulmann, Jamila Wegener, Jamila Wegener, Enrica Marzani, Gustavo Ferreira Alves, Massimo Collino, Sina Maren Coldewey, Sina Maren Coldewey, Christoph Thiemermann

    Published 2024-11-01
    “…Thus, we investigated the effects of the highly selective SYK inhibitor PRT062607 (15mg/kg; i.p.) on sepsis-induced cardiac dysfunction and MOF in a clinically-relevant, murine model of sepsis. …”
    Get full text
    Article
  15. 1175

    Exosome‐Mediated Lectin Pathway and Resistin‐MIF‐AA Metabolism Axis Drive Immune Dysfunction in Immune Thrombocytopenia by Jin Li, Xiaoqian Wang, Yaoyao Chen, Xianlei Sun, Liyan Fu, Qingxuan Xin, Huilin Zhang, Bo Qin, Nannan Sun, Yingmei Li, Yan Xu, Hui Yang, Dawei Huo, Yong Dong, Shuya Wang, Mengyun Zhao, Quande Lin, Fang Wang, Baohong Yue, Yanxia Gao, Yong Jiang, Rongqun Guo

    Published 2025-03-01
    “…In this study, using flow cytometry (FCM), proteomics, and single‐cell RNA sequencing of samples from patients with ITP, it is shown that exosome‐mediated lectin complement pathway is involved in the pathogenesis of ITP, which triggers and enlarges the complement activation cascade without effective regulation because of downregulated CD55. …”
    Get full text
    Article
  16. 1176
  17. 1177
  18. 1178
  19. 1179

    Oral azithromycin versus doxycycline in meibomian gland dysfunction: A hospital-based study at Nepal eye hospital by Sabita Dhakal, Sabina Shrestha, Pooja Karki, Sujata Dhakal

    Published 2025-04-01
    “…Background: Meibomian gland dysfunction (MGD) involves posterior blepharitis, which includes a disruption of the tear and meibum lipids and thereby produces an evaporative dry eye. …”
    Get full text
    Article
  20. 1180

    l-carnitine protects against bile acid-induced mitochondrial dysfunction and IGF-1 impairment in hepatocyte cultures by Wafa'a Alqabandi, Maira Alsaeid, Gursev Dhaunsi

    Published 2025-06-01
    “…Conclusions: GCDC-induced hepatotoxic effects could be triggered by mitochondrial dysfunction and impairment of IGF-1 activity. …”
    Get full text
    Article